Bioxydyn Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
2ndary - Private
Bioxydyn General Information
Description
Developer of diagnostic imaging tools designed to provide insights into disease progression and drug effects. The company's services and tools are used in a range of disease areas, including respiratory disease, neurological conditions, oncological diseases, and inflammatory disorders, enabling physicians to monitor and characterize diseases accurately.
Contact Information
Website
www.bioxydyn.comCorporate Office
- Saint James Tower
- 7 Charlotte Street
- Manchester M1 4DZ
- England, United Kingdom
Corporate Office
- Saint James Tower
- 7 Charlotte Street
- Manchester M1 4DZ
- England, United Kingdom
Bioxydyn Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | 01-Sep-2021 | Completed | Generating Revenue | |||
| 7. Grant | 01-Mar-2019 | Completed | Generating Revenue | |||
| 6. Grant | 01-Dec-2014 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 19-Feb-2014 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 04-Oct-2012 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 27-Sep-2011 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 12-May-2010 | $144K | $144K | Completed | Generating Revenue | |
| 1. University Spin-Out | 05-Mar-2009 | Completed | Startup |
Bioxydyn Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary B1 | ||||||||
| Ordinary B | ||||||||
| Ordinary A | 2,590 | $60.47 | $60.47 | 1x | $60.47 | 7.84% |
Bioxydyn Comparisons
Industry
Financing
Details
Bioxydyn Competitors (2)
One of Bioxydyn’s 2 competitors is IXICO, a Formerly VC-backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| IXICO | Formerly VC-backed | London, United Kingdom | ||||
| Antaros Medical | Private Equity-Backed | Molndal, Sweden |
Bioxydyn Patents
Bioxydyn Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160166212-A1 | Lung function analysis method and apparatus | Inactive | 03-Nov-2009 | ||
| EP-2496952-A1 | Lung function analysis method and apparatus | Active | 03-Nov-2009 | ||
| EP-2496952-B1 | Lung function analysis method and apparatus | Inactive | 03-Nov-2009 | ||
| US-20120215504-A1 | Lung function analysis method and apparatus | Active | 03-Nov-2009 | ||
| US-9289156-B2 | Lung function analysis method and apparatus | Inactive | 03-Nov-2009 | A61B5/083 |
Bioxydyn Signals
Bioxydyn FAQs
-
When was Bioxydyn founded?
Bioxydyn was founded in 2009.
-
Where is Bioxydyn headquartered?
Bioxydyn is headquartered in Manchester, United Kingdom.
-
What is the size of Bioxydyn?
Bioxydyn has 12 total employees.
-
What industry is Bioxydyn in?
Bioxydyn’s primary industry is Diagnostic Equipment.
-
Is Bioxydyn a private or public company?
Bioxydyn is a Private company.
-
What is Bioxydyn’s current revenue?
The current revenue for Bioxydyn is .
-
How much funding has Bioxydyn raised over time?
Bioxydyn has raised $3.4M.
-
Who are Bioxydyn’s competitors?
IXICO and Antaros Medical are competitors of Bioxydyn.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process